Liposomal Vitamins: Optimising Bioavilablity

With the daily supplementation of vitamins continuing to grow in popularity, many people remain unaware that vitamins are governed by no standard regulatory, scientific or marketplace definitions. This leads to inconsistencies in dosing and formulation, raising questions about the bioavailability upon ingestion. This article investigates how high-pressure homogenisation facilitates liposome encapsulation to transport vitamins into the bloodstream, thus increasing the absorption and benefit of the proportional amount of API within the supplement. This helps tackle the bioavailability issues for the multivitamin industry and users by reducing the risk of toxicity caused by increased usage to counteract ineffective results.

For more information on Liposomal Vitamins: Optimising Bioavilablity talk to Biopharma Group